ALLIANCEBERNSTEIN L.P.

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$274,032

+$205,328 QoQ

Shares Held

39,600

+30.3% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 126 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. RLMD ranks #205 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,019,315	$1,499,784,339
2	ARGX	Argenx SE	395,661	$367,082,405
3	GMAB	Genmab A/S	8,644,877	$237,474,771
4	REGN	Regeneron Pharmaceuticals, Inc.	292,338	$182,284,436
5	TECH	BIO-TECHNE Corp	2,002,026	$141,443,136
6	HALO	Halozyme Therapeutics, Inc.	1,696,538	$132,788,029
7	KYMR	Kymera Therapeutics, Inc.	981,521	$112,551,013
8	BBIO	BridgeBio Pharma, Inc.	1,453,504	$108,256,977

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,032	39,600	+30.3%	Shares	Defined	2026-08-14
2023-03-31	$68,704	30,400	0.0%	Shares	Defined	2023-05-15
2022-12-31	$106,096	30,400	+69.8%	Shares	Defined	2023-02-15
2022-09-30	$662,658	17,900	-76.8%	Shares	Defined	2022-11-15
2022-06-30	$1,462,837	77,032	+330.3%	Shares	Defined	2022-08-15
2022-03-31	$483,121	17,900	0.0%	Shares	Defined	2022-05-13
2021-12-31	$403,287	17,900	0.0%	Shares	Defined	2022-02-14
2021-09-30	$469,159	17,900	0.0%	Shares	Defined	2021-11-10
2021-06-30	$572,979	17,900	+14.0%	Shares	Defined	2021-07-30
2021-03-31	$552,797	15,700	0.0%	Shares	Defined	2021-05-06
2020-12-31	$503,499	15,700	-9.8%	Shares	Defined	2021-02-08
2020-09-30	$654,588	17,400	-3.3%	Shares	Defined	2020-11-12
2020-06-30	$805,500	18,000	—	Shares	Defined	2020-08-13
No filing history on record for this holder in this stock.